The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Safe Sex and HIV PreventionSafe Sex and HIV Prevention
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Alternative Protease inhibitior

Nov 15, 2010

Dear Dr Franscino, My wife was occupationally exposed (blooded blade) at work with a known HIV+ patient (CD4 120, viral load unknown). She was given Combivir within the hour but at my insistence (both surgeons) I added Aluvia (developing-world equivalent for Kaletra). Her vomiting stopped with 5HT blockers (ondansatron) but generally she is feeling awful (lethargy, nausea etc). Can you tell me if it is safe to try an alternative PI during the 28 day PEP period? Are some PIs better tolerated than others? I do not have access to an HIV specialist for advice, but can prescribe certain drugs if they are available here. Thanks, DG (South Africa)

Response from Dr. Frascino

Hello DG,

Yes, it's perfectly reasonable to switch to an alternative protease inhibitor if your wife is not tolerating Kaletra. Ritonavir-boosted atazanavir or darunavir would be options.

Good luck.

Dr. Bob

Thank you and fungal recurrence question
hey Dr. B Porn guy stoppin by

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint